Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003145506 | SCV003828919 | uncertain significance | not provided | 2020-11-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001278217 | SCV005727781 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2025-01-28 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 142 of the CAPN3 protein (p.Gln142Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CAPN3-related conditions. ClinVar contains an entry for this variant (Variation ID: 990237). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CAPN3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001278217 | SCV001465213 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2020-04-17 | no assertion criteria provided | clinical testing |